pseudomyxoma peritonei
pseudomyxoma peritonei
Explore linked clinical trials. Standard reference: MONDO:001704816 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE) | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, pseudomyxoma peritonei | Not yet recruiting | Phase 2 | 2026-09-24 | NCT06084780 | |
| Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed | Abdominal Neoplasms, Body Temperature Changes, Digestive System Diseases, Digestive System Neoplasms, Fever, Neoplasms by Histologic Type, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Peritoneal Diseases, Signs and Symptoms, adenocarcinoma, carcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, peritoneal mesothelioma, peritoneal neoplasm, pseudomyxoma peritonei | Recruiting | Not stated | 2026-09-03 | NCT01617382 | |
| The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry | Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Peritoneal Diseases, adenocarcinoma, appendiceal neoplasm, carcinoma, cecal disorder, cecal neoplasm, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, mucinous adenocarcinoma, neoplasm, peritoneal neoplasm, pseudomyxoma peritonei | Recruiting | Not stated | 2026-08-17 | NCT07769346 | |
| Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, pseudomyxoma peritonei | Recruiting | Phase 2 | 2026-07-13 | NCT07693452 | |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | Adnexal Diseases, Bartholin gland transitional cell carcinoma, Biliary Tract Neoplasms, Carcinoma, Endometrioid, Cystadenocarcinoma, Serous, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Gestational Trophoblastic Disease, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Fibrous Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Nose Neoplasms, Otorhinolaryngologic Neoplasms, Parathyroid Neoplasms, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pharyngeal Diseases, Pregnancy Complications, Neoplastic, Rare Diseases, Stomatognathic Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, acinar cell carcinoma, adenocarcinoma, adenoid cystic carcinoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, adrenal gland pheochromocytoma, angiosarcoma, apocrine sweat gland neoplasm, basal cell carcinoma, basal cell neoplasm, bile duct disorder, bile duct neoplasm, biliary tract disorder, bladder adenocarcinoma, carcinoma, carcinosarcoma, cervical adenocarcinoma, cholangiocarcinoma, chordoma, colorectal squamous cell carcinoma, connective tissue neoplasm, cystadenocarcinoma, cystic, mucinous, and serous neoplasm, desmoid tumor, digestive system disorder, digestive system neoplasm, endocrine system disorder, endometrial transitional cell carcinoma, endometrium neoplasm, epithelial neoplasm, extrahepatic bile duct carcinoma, extramammary Paget disease, fallopian tube adenocarcinoma, fallopian tube transitional cell carcinoma, female reproductive system disorder, female reproductive system neoplasm, fibroma, fibromyxoid tumor, fibrosarcoma, gallbladder carcinoma, gallbladder disorder, gallbladder neoplasm, gastric squamous cell carcinoma, gastrointestinal stromal tumor, germinoma, gestational trophoblastic neoplasm, gonadal disorder, intrahepatic cholangiocarcinoma, lung adenocarcinoma, lung giant cell carcinoma, lung neoplasm, lung neuroendocrine neoplasm, lung sarcomatoid carcinoma, major salivary gland carcinoma, malignant endocrine neoplasm, minimally invasive lung adenocarcinoma, mixed neoplasm, mouth disorder, mucinous adenocarcinoma, mucinous adenocarcinoma of the appendix, mucinous cystadenocarcinoma, nasal cavity adenocarcinoma, nasal cavity carcinoma, nasal disorder, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, neoplasm with perivascular epithelioid cell differentiation, nerve sheath neoplasm, nervous system disorder, neuroendocrine carcinoma, neuroendocrine neoplasm, neurofibroma, neurofibrosarcoma, neuromuscular disease, oral cavity carcinoma, otorhinolaryngologic disease, ovarian adenocarcinoma, ovarian cancer, ovarian disorder, ovarian germ cell tumor, ovarian mucinous adenocarcinoma, ovarian squamous cell carcinoma, ovarian transitional cell carcinoma, pancreas disorder, pancreatic acinar cell carcinoma, pancreatic endocrine carcinoma, pancreatic neoplasm, paraganglioma, paranasal sinus carcinoma, paranasal sinus disorder, paranasal sinus neoplasm, parathyroid gland carcinoma, parathyroid gland disorder, peripheral nervous system disorder, peripheral nervous system neoplasm, pheochromocytoma, placental choriocarcinoma, pregnancy disorder, primitive neuroectodermal tumor, pseudomyxoma peritonei, respiratory system disorder, respiratory tract neoplasm, sarcoma, scrotum squamous cell carcinoma, seminal vesicle adenocarcinoma, seminoma, small intestine adenocarcinoma, somatostatinoma, spindle cell neoplasm, squamous cell carcinoma of penis, squamous cell carcinoma of the small intestine, testicular non-seminomatous germ cell tumor, thyroid gland carcinoma, thyroid gland disorder, thyroid tumor, trachea carcinoma, transitional cell carcinoma, trophoblastic neoplasm, undifferentiated carcinoma of esophagus, undifferentiated carcinoma of nasopharynx, undifferentiated carcinoma of stomach, ureter adenocarcinoma, ureter squamous cell carcinoma, urethra adenocarcinoma, urethra squamous cell carcinoma, vaginal adenocarcinoma, vascular cancer, vulva cancer, vulvar carcinoma, vulvar disease | Active, not recruiting | Phase 2 | 2026-06-17 | NCT02834013 | |
| Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC | Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Peritoneal Diseases, adenocarcinoma, appendiceal neoplasm, carcinoma, cecal disorder, cecal neoplasm, colonic disorder, colorectal neoplasm, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, mucinous adenocarcinoma, neoplasm, peritoneal neoplasm, pseudomyxoma peritonei, rectal disorder | Recruiting | Phase 2 | 2026-04-01 | NCT04779554 | |
| Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, adenocarcinoma, blood coagulation disease, carcinoma, coagulation protein disease, congenital afibrinogenemia, cystic, mucinous, and serous neoplasm, epithelial neoplasm, hematologic disorder, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, mucinous adenocarcinoma, neoplasm, pseudomyxoma peritonei | Recruiting | Phase 3 | 2026-03-11 | NCT06617897 | |
| Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management. | Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Hernia, Hernia, Abdominal, Hernia, Ventral, Neoplasms by Histologic Type, Neoplasms by Site, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Peritoneal Diseases, adenocarcinoma, carcinoma, colonic disorder, colorectal neoplasm, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, mucinous adenocarcinoma, neoplasm, peritoneal neoplasm, pseudomyxoma peritonei, rectal disorder | Recruiting | Not stated | 2026-03-05 | NCT07451483 | |
| Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP) | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, pseudomyxoma peritonei | Recruiting | Phase 3 | 2026-02-19 | NCT06513065 | |
| Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium | Confusion, Emergence Delirium, Neoplasms by Histologic Type, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, adenocarcinoma, carcinoma, cognitive disorder, cystic, mucinous, and serous neoplasm, delirium, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, nervous system disorder, pseudomyxoma peritonei, psychiatric disorder | Not yet recruiting | Not applicable | 2026-01-30 | NCT07378371 | |
| Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis | Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Peritoneal Diseases, adenocarcinoma, carcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, peritoneal neoplasm, pseudomyxoma peritonei | Recruiting | Not applicable | 2026-01-16 | NCT04024917 | |
| Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, pseudomyxoma peritonei | Recruiting | Early phase 1 | 2026-01-14 | NCT07341360 | |
| One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, pseudomyxoma peritonei | Recruiting | Not applicable | 2026-01-09 | NCT07328737 | |
| Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, pseudomyxoma peritonei | Recruiting | Phase 2 | 2025-01-30 | NCT06800391 | |
| Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, appendiceal neoplasm, carcinoma, cecal disorder, cecal neoplasm, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, mucinous adenocarcinoma, neoplasm, pseudomyxoma peritonei | Active, not recruiting | Phase 2 | 2024-11-19 | NCT02387203 | |
| Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies | Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Peritoneal Diseases, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, adenoma, carcinoma, colonic disorder, colorectal neoplasm, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, intestinal disorder, malignant endocrine neoplasm, mesothelial neoplasm, mesothelioma, mucinous adenocarcinoma, neoplasm, ovarian cancer, ovarian carcinoma, ovarian disorder, peritoneal neoplasm, pseudomyxoma peritonei, rectal disorder | Recruiting | Not stated | 2021-07-28 | NCT02073500 |